The potential of nanoparticle vaccines as a treatment for cancer

David Urbanavicius, Tara Alvarez, Georgina K. Such, Angus P.R. Johnston, Justine D. Mintern

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

A complex and multifaceted relationship exists between cancer and the immune system. Advances in our understanding of this relationship have resulted in significant clinical attention in the possibilities of cancer immunotherapy. Harnessing the immune system's potent and selective destructive capability is a major focus of attempts to treat cancer. Despite significant progress in the field, cancer therapy still remains significantly deficient, with cancer being one of the largest contributors to morbidity and mortality in the developed world. It is evident that the design of new treatment regimes is required to exploit cancer immunotherapy. Herein we review the potential for nanotechnology to overcome the challenges that have limited the more widespread implementation of immunotherapy to cancer treatment.

Original languageEnglish
Pages (from-to)2-7
Number of pages6
JournalMolecular Immunology
Volume98
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • Cancer immunotherapy
  • Nanoparticles
  • Vaccines

Cite this

Urbanavicius, David ; Alvarez, Tara ; Such, Georgina K. ; Johnston, Angus P.R. ; Mintern, Justine D. / The potential of nanoparticle vaccines as a treatment for cancer. In: Molecular Immunology. 2018 ; Vol. 98. pp. 2-7.
@article{06d3227918a54f799801f96229210b53,
title = "The potential of nanoparticle vaccines as a treatment for cancer",
abstract = "A complex and multifaceted relationship exists between cancer and the immune system. Advances in our understanding of this relationship have resulted in significant clinical attention in the possibilities of cancer immunotherapy. Harnessing the immune system's potent and selective destructive capability is a major focus of attempts to treat cancer. Despite significant progress in the field, cancer therapy still remains significantly deficient, with cancer being one of the largest contributors to morbidity and mortality in the developed world. It is evident that the design of new treatment regimes is required to exploit cancer immunotherapy. Herein we review the potential for nanotechnology to overcome the challenges that have limited the more widespread implementation of immunotherapy to cancer treatment.",
keywords = "Cancer immunotherapy, Nanoparticles, Vaccines",
author = "David Urbanavicius and Tara Alvarez and Such, {Georgina K.} and Johnston, {Angus P.R.} and Mintern, {Justine D.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.molimm.2017.12.022",
language = "English",
volume = "98",
pages = "2--7",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier",

}

The potential of nanoparticle vaccines as a treatment for cancer. / Urbanavicius, David; Alvarez, Tara; Such, Georgina K.; Johnston, Angus P.R.; Mintern, Justine D.

In: Molecular Immunology, Vol. 98, 01.06.2018, p. 2-7.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - The potential of nanoparticle vaccines as a treatment for cancer

AU - Urbanavicius, David

AU - Alvarez, Tara

AU - Such, Georgina K.

AU - Johnston, Angus P.R.

AU - Mintern, Justine D.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - A complex and multifaceted relationship exists between cancer and the immune system. Advances in our understanding of this relationship have resulted in significant clinical attention in the possibilities of cancer immunotherapy. Harnessing the immune system's potent and selective destructive capability is a major focus of attempts to treat cancer. Despite significant progress in the field, cancer therapy still remains significantly deficient, with cancer being one of the largest contributors to morbidity and mortality in the developed world. It is evident that the design of new treatment regimes is required to exploit cancer immunotherapy. Herein we review the potential for nanotechnology to overcome the challenges that have limited the more widespread implementation of immunotherapy to cancer treatment.

AB - A complex and multifaceted relationship exists between cancer and the immune system. Advances in our understanding of this relationship have resulted in significant clinical attention in the possibilities of cancer immunotherapy. Harnessing the immune system's potent and selective destructive capability is a major focus of attempts to treat cancer. Despite significant progress in the field, cancer therapy still remains significantly deficient, with cancer being one of the largest contributors to morbidity and mortality in the developed world. It is evident that the design of new treatment regimes is required to exploit cancer immunotherapy. Herein we review the potential for nanotechnology to overcome the challenges that have limited the more widespread implementation of immunotherapy to cancer treatment.

KW - Cancer immunotherapy

KW - Nanoparticles

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=85040933106&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2017.12.022

DO - 10.1016/j.molimm.2017.12.022

M3 - Review Article

VL - 98

SP - 2

EP - 7

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

ER -